関連する実験動画
Updated: Jul 5, 2026

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
利尿薬と,左心室機能不全の患者における不律性死のリスク
H A Cooper1, D L Dries, C E Davis
1Clinical Trials Scientific Research Group, Division of Epidemiology and Clinical Applications, National Heart, Lung, and Blood Institute, Bethesda, MD 20892, USA. Cooperh@nih.gov
Circulation
|September 24, 1999
まとめ
非カリウム貯蔵性利尿薬は,シストリック左心室機能不全の患者における不律性死のリスクを高めます. カリウムを節約する利尿薬は,SOLVD研究でこの関連性を示しませんでした.
科学分野:
- 心臓病学 心臓病学
- 薬理学 薬理学とは
- クリニック・リサーチ 臨床研究
背景:
- 利尿剤の使用は,高血圧患者における不律性死のリスクの増加と関連しています.
- 左心室機能不全の患者における不律性死に対する利尿薬療法の影響は不明である.
研究 の 目的:
- シストリック左心室機能不全の患者において,発症時の利尿剤の使用と不律性死のリスクとの関連性を調査する.
主な方法:
- 左心室機能障害研究 (SOLVD) のコホートから6797人の患者を遡及的に分析した.
- ベースラインでの尿薬使用と,その後の不律性死亡事件の評価.
- 統計分析における関連する共変数に対して制御される.
主要な成果:
- ベースラインでの利尿剤の使用は,不律性死亡のより高い割合 (3.1対100人年当たり1.7対,P=0.001) と関連していました.
- 非カリウム節約性利尿剤の使用は,無関係に不律性死亡のリスクが増加した (RR 1.33,P=0.02).
- カリウム貯蔵性利尿剤の使用は,単独または併用では,リズム不良による死亡リスクの増加と独立して関連していなかった (RR 0.90,P = 0.6).
結論:
- 非カリウム節約性利尿剤のベースライン使用は,シストリック左心室機能不全の患者における不律性死亡リスクの増加と関連しています.
- カリウムを節約する利尿薬は,このリスクの増加と関連していなかった.
- 利尿剤によって引き起こされる電解質の不均衡は,この患者集団における致死性不律症に寄与する可能性があります.
関連する概念動画
Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiac Catheterization IV: Nursing Management
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...

